Cargando...
Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid
BACKGROUND. Thymic atypical carcinoid (TAC) is a rare thymic neuroendocrine tumor that originates in the neuroendocrine system and lacks a standardized treatment. The combination of capecitabine (CAP) and temozolomide (TEM) is associated with an extremely high and long‐lasting response rate in patie...
Guardado en:
| Publicado en: | Oncologist |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656479/ https://ncbi.nlm.nih.gov/pubmed/30413666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0291 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|